Retrospective Cohort Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jun 14, 2016; 22(22): 5237-5245
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5237
Table 4 Result of the univariate and multivariate analysis of prognostic factors for cancer-specific survival
FactornUnivariate analysis
Multivariate analysis
3-yr CSS5-yr CSSP valueHR(95%CI)P value
GenderM14188.3%80.8%0.924
F9387.8%79.7%
Age (yr)≥ 759682.2%71.6%0.0271.464 (0.647-3.310)0.360
< 7513891.9%85.4%
ASA-PS17186.0%83.5%0.710
2-316389.0%78.7%
BMI (kg/m2)≥ 252892.0%85.8%0.389
< 2519387.3%80.0%
Serum albumin (g/dL) ≤ 4.017285.6%82.6%0.536
> 4.04887.7%76.2%
CEA (mg/dL)≥ 5.010286.7%80.0%0.715
< 5.011390.5%82.0%
Decompression+18388.4%81.7%0.514
-5187.1%74.8%
Location of tumorRight side6982.6%70.5%0.103
Left side16590.4%84.3%
Tumor size (mm)≥ 509984.1%76.9%0.291
< 5012190.4%85%
Differentiation of tumortub1, tub222289.9%82.5%0.0016.282 (1.584-24.909)0.009
por, muc1250.0%50.0%
Depth of tumorT310895.7%92.3%0.0013.458 (1.324-9.031)0.011
T412681.1%69.2%
Intramural lymphatic invasion+15790.8%82.7%0.449
-7386.9%79.4%
Intramural vascular invasion+16494.2%90.1%0.152
-7085.9%76.7%
Lymph node involvement+12092.5%82.9%0.332
-11484.0%77.7%
Lymph node dissectionD0, D13160.7%60.7%0.0140.958 (0.300-3.056)0.942
D2, D319990.4%83.0%
No. of lymph nodes harvested< 127383.3%78.3%0.314
≥ 1215191.1%81.0%
Postoperative complication+7885.9%75.6%0.644
(≥ Grade 2)-15689%82.5%
Anastomotic leakage+18100%100%0.069
-19187.1%78.7%
CurabilityR021991.3%84.7%< 0.0016.162 (1.692-22.445)0.006
R11539.7%19.9%
Adjuvant chemotherapy+9187.7%81.8%0.800
-14388.8%79.4%